LCP2
Lymphocyte cytosolic protein 2
Also known as: LCP2_HUMAN, SLP-76, SLP76
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13094
- Gene
- LCP2
- Ensembl
- ENSG00000043462
- Chromosome
- 5
- Canonical length
- 533 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes an adapter protein that acts as a substrate of the T cell antigen receptor (TCR)-activated protein tyrosine kinase pathway. The encoded protein associates with growth factor receptor bound protein 2, and is thought to play a role TCR-mediated intracellular signal transduction. A similar protein in mouse plays a role in normal T-cell development and activation. Mice lacking this gene show subcutaneous and intraperitoneal fetal hemorrhaging, dysfunctional platelets and impaired viability. [provided by RefSeq, Nov 2016]
Canonical amino-acid sequenceUniProt
533 residues, UniProt reviewed canonical sequence.
>Q13094|LCP2
1 MALRNVPFRS EVLGWDPDSL ADYFKKLNYK DCEKAVKKYH IDGARFLNLT ENDIQKFPKL
61 RVPILSKLSQ EINKNEERRS IFTRKPQVPR FPEETESHEE DNGGWSSFEE DDYESPNDDQ
121 DGEDDGDYES PNEEEEAPVE DDADYEPPPS NDEEALQNSI LPAKPFPNSN SMYIDRPPSG
181 KTPQQPPVPP QRPMAALPPP PAGRNHSPLP PPQTNHEEPS RSRNHKTAKL PAPSIDRSTK
241 PPLDRSLAPF DREPFTLGKK PPFSDKPSIP AGRSLGEHLP KIQKPPLPPT TERHERSSPL
301 PGKKPPVPKH GWGPDRREND EDDVHQRPLP QPALLPMSSN TFPSRSTKPS PMNPLPSSHM
361 PGAFSESNSS FPQSASLPPY FSQGPSNRPP IRAEGRNFPL PLPNKPRPPS PAEEENSLNE
421 EWYVSYITRP EAEAALRKIN QDGTFLVRDS SKKTTTNPYV LMVLYKDKVY NIQIRYQKES
481 QVYLLGTGLR GKEDFLSVSD IIDYFRKMPL LLIDGKNRGS RYQCTLTHAA GYPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LCP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 155 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 155 nTPM
- thymus: 107 nTPM
- spleen: 76 nTPM
- lymph node: 73 nTPM
- appendix: 71 nTPM
- tonsil: 44 nTPM
Single-cell type
- neutrophils: 3,949 nCPM
- monocytes: 858 nCPM
- macrophages: 453 nCPM
- neutrophil progenitors: 452 nCPM
- kupffer cells: 426 nCPM
- mast cells: 270 nCPM
Immune cell
- eosinophil: 77 nTPM
- neutrophil: 69 nTPM
- non-classical monocyte: 66 nTPM
- basophil: 57 nTPM
- intermediate monocyte: 43 nTPM
- NK-cell: 42 nTPM
Brain region
- cerebral cortex: 45 nTPM
- white matter: 23 nTPM
- medulla oblongata: 22 nTPM
- pons: 20 nTPM
- thalamus: 18 nTPM
- midbrain: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LCP2.
Disease | AllUniProt
Conditions LCP2 is implicated in, by any mechanism.
- Immunodeficiency 81 (IMD81) MIM:619374
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 111 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency 81
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.34
- gnomAD pLI
- 0.92
- gnomAD missense Z
- 0.92
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor protein tyrosine kinase signaling pathway
- immune response
- intracellular signal transduction
- mast cell activation
- positive regulation of protein kinase activity
- T cell receptor signaling pathway
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LCP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LCP2 as an antibody target. Whether an autoantibody or antibody against LCP2 could matter depends on whether native LCP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LCP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LCP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...